Science Translational Medicine -- Purchase Short-Term Access

Purchase Short-Term Access

A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
Scott et al. Sci Transl Med 2016 8 (341), p. 341ra76



 required


Your receipt will be sent to this email address. If you have previously purchased access to content on this site, please enter the same email address so we can detect any duplicate purchases.

You may view, download, and/or print the article for your personal scholarly, research, and educational use. You may not (i) distribute a copy (electronic or otherwise) of the article without the written permission of AAAS, (ii) post the article on an electronic bulletin board or web site, or (iii) charge for a copy (electronic or otherwise) of the article.